Literature DB >> 25287162

Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination.

Laetitia Wioland1, Jean-Luc Dupont, Frédéric Doussau, Stéphane Gaillard, Flavia Heid, Philippe Isope, Serge Pauillac, Michel R Popoff, Jean-Louis Bossu, Bernard Poulain.   

Abstract

Epsilon toxin (ET) is produced by Clostridium perfringens types B and D and causes severe neurological disorders in animals. ET has been observed binding to white matter, suggesting that it may target oligodendrocytes. In primary cultures containing oligodendrocytes and astrocytes, we found that ET (10(-9) M and 10(-7) M) binds to oligodendrocytes, but not to astrocytes. ET induces an increase in extracellular glutamate, and produces oscillations of intracellular Ca(2+) concentration in oligodendrocytes. These effects occurred without any change in the transmembrane resistance of oligodendrocytes, underlining that ET acts through a pore-independent mechanism. Pharmacological investigations revealed that the Ca(2+) oscillations are caused by the ET-induced rise in extracellular glutamate concentration. Indeed, the blockade of metabotropic glutamate receptors type 1 (mGluR1) prevented ET-induced Ca(2+) signals. Activation of the N-methyl-D-aspartate receptor (NMDA-R) is also involved, but to a lesser extent. Oligodendrocytes are responsible for myelinating neuronal axons. Using organotypic cultures of cerebellar slices, we found that ET induced the demyelination of Purkinje cell axons within 24 h. As this effect was suppressed by antagonizing mGluR1 and NMDA-R, demyelination is therefore caused by the initial ET-induced rise in extracellular glutamate concentration. This study reveals the novel possibility that ET can act on oligodendrocytes, thereby causing demyelination. Moreover, it suggests that for certain cell types such as oligodendrocytes, ET can act without forming pores, namely through the activation of an undefined receptor-mediated pathway.
© 2014 The Authors. Cellular Microbiology published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25287162     DOI: 10.1111/cmi.12373

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  16 in total

1.  F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.

Authors:  Jingjing Kang; Jie Gao; Wenwu Yao; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Jiahao Yao; Wenwen Xin; Baohua Zhao; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-17       Impact factor: 3.452

2.  The Cytotoxicity of Epsilon Toxin from Clostridium perfringens on Lymphocytes Is Mediated by MAL Protein Expression.

Authors:  Marta Blanch; Jonatan Dorca-Arévalo; Anna Not; Mercè Cases; Inmaculada Gómez de Aranda; Antonio Martínez-Yélamos; Sergio Martínez-Yélamos; Carles Solsona; Juan Blasi
Journal:  Mol Cell Biol       Date:  2018-09-14       Impact factor: 4.272

Review 3.  Bacterial Signaling to the Nervous System through Toxins and Metabolites.

Authors:  Nicole J Yang; Isaac M Chiu
Journal:  J Mol Biol       Date:  2017-01-06       Impact factor: 5.469

4.  New Mutants of Epsilon Toxin from Clostridium perfringens with an Altered Receptor-Binding Site and Cell-Type Specificity.

Authors:  Jonatan Dorca-Arévalo; Inmaculada Gómez de Aranda; Juan Blasi
Journal:  Toxins (Basel)       Date:  2022-04-16       Impact factor: 5.075

5.  Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.

Authors:  Jennifer R Linden; Yinghua Ma; Baohua Zhao; Jason Michael Harris; Kareem Rashid Rumah; Nicole Schaeren-Wiemers; Timothy Vartanian
Journal:  MBio       Date:  2015-06-16       Impact factor: 7.867

6.  Acute Effect of Pore-Forming Clostridium perfringens ε-Toxin on Compound Action Potentials of Optic Nerve of Mouse.

Authors:  Mercè Cases; Artur Llobet; Beatrice Terni; Inmaculada Gómez de Aranda; Marta Blanch; Briain Doohan; Alexander Revill; Angus M Brown; Juan Blasi; Carles Solsona
Journal:  eNeuro       Date:  2017-08-10

7.  Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens.

Authors:  Kareem R Rumah; Timothy K Vartanian; Vincent A Fischetti
Journal:  Front Cell Infect Microbiol       Date:  2017-01-25       Impact factor: 5.293

Review 8.  Mechanisms of Action and Cell Death Associated with Clostridium perfringens Toxins.

Authors:  Mauricio A Navarro; Bruce A McClane; Francisco A Uzal
Journal:  Toxins (Basel)       Date:  2018-05-22       Impact factor: 4.546

9.  Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis.

Authors:  Sariqa Wagley; Monika Bokori-Brown; Helen Morcrette; Andrea Malaspina; Caroline D'Arcy; Sharmilee Gnanapavan; Nicholas Lewis; Michel R Popoff; Dominika Raciborska; Richard Nicholas; Ben Turner; Richard W Titball
Journal:  Mult Scler       Date:  2018-04-21       Impact factor: 6.312

10.  Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.

Authors:  Carles Gil; Jonatan Dorca-Arévalo; Juan Blasi
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.